lemuel-a-moye documents

Sizing clinical trials with variable endpoint event rates
Documents Sizing clinical trials with variable endpoint event rates
Response to commentaries on ‘Alpha calculus in clinical trials: considerations for the new millennium’
Documents Response to commentaries on ‘Alpha calculus in clinical trials: considerations for the new millennium’
Rejoinder: The new adversary
Documents Rejoinder: The new adversary
Analysis of a clinical trial involving a combined mortality and adherence dependent interval censored endpoint
Documents Analysis of a clinical trial involving a combined mortality and adherence dependent interval censored endpoint
Rationale, design and baseline characteristics of the survival and ventricular enlargement trial
Documents Rationale, design and baseline characteristics of the survival and ventricular enlargement trial
Response to McMahon and Lange
Documents Response to McMahon and Lange
62A Decision rules for predicting future lipid values in a cholesterol reduction clinical trial
Documents 62A Decision rules for predicting future lipid values in a cholesterol reduction clinical trial
Rudiments of Subgroup Analyses
Documents Rudiments of Subgroup Analyses
Trials within Trials: Confirmatory Subgroup Analyses in Controlled Clinical Experiments
Documents Trials within Trials: Confirmatory Subgroup Analyses in Controlled Clinical Experiments
End-Point Interpretation in Clinical Trials: The Case for Discipline
Documents End-Point Interpretation in Clinical Trials: The Case for Discipline
Statistical Monitoring of Clinical Trials: Fundamentals for Investigators
Documents Statistical Monitoring of Clinical Trials: Fundamentals for Investigators